Huateng Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 400

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Huateng Pharma General Information

Description

Developer of biomedical chemical products. The company's products include PEG derivatives, intermediates, excipients, APIs and reagents, enabling patients and hospitals to receive the drug treatment necessary to cure diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building E1, Lugu Corporation Plaza
  • High-Tech Industrial Development Zone
  • Changsha, Hunan 410205
  • China
+86 0731
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Building E1, Lugu Corporation Plaza
  • High-Tech Industrial Development Zone
  • Changsha, Hunan 410205
  • China
+86 0731

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huateng Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 02-Dec-2022 Completed Generating Revenue
3. Later Stage VC 21-Dec-2021 Completed Generating Revenue
2. Later Stage VC (Series B) 10-May-2021 $18M $25M Completed Generating Revenue
1. Later Stage VC (Series A) 24-Sep-2019 $7.02M $7.02M Completed Generating Revenue
To view Huateng Pharma’s complete valuation and funding history, request access »

Huateng Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Huateng Pharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Go Win Investment Venture Capital Minority
Guangzhou Nanyue Aode Investment Venture Capital Minority
Citic Securities Investment Investment Bank Minority
Xingxiang Investment Holding Group Asset Manager Minority
Chongqing Boyi Equity Investment Fund Management Growth/Expansion Minority
To view Huateng Pharma’s complete investors history, request access »

Huateng Pharma FAQs

  • When was Huateng Pharma founded?

    Huateng Pharma was founded in 2013.

  • Where is Huateng Pharma headquartered?

    Huateng Pharma is headquartered in Changsha, China.

  • What is the size of Huateng Pharma?

    Huateng Pharma has 400 total employees.

  • What industry is Huateng Pharma in?

    Huateng Pharma’s primary industry is Drug Discovery.

  • Is Huateng Pharma a private or public company?

    Huateng Pharma is a Private company.

  • What is Huateng Pharma’s current revenue?

    The current revenue for Huateng Pharma is .

  • How much funding has Huateng Pharma raised over time?

    Huateng Pharma has raised $25M.

  • Who are Huateng Pharma’s investors?

    Go Win Investment, Guangzhou Nanyue Aode Investment, Citic Securities Investment, Xingxiang Investment Holding Group, and Chongqing Boyi Equity Investment Fund Management have invested in Huateng Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process